INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,110 | -23.5% | 7,562 | -1.4% | 0.00% | -100.0% |
| Q2 2023 | $312,741 | +96.2% | 7,669 | +79.3% | 0.00% | – |
| Q1 2023 | $159,366 | -10.3% | 4,276 | -16.0% | 0.00% | – |
| Q4 2022 | $177,659 | -38.3% | 5,092 | -1.3% | 0.00% | -100.0% |
| Q3 2022 | $288,000 | +2.1% | 5,157 | -5.4% | 0.00% | – |
| Q2 2022 | $282,000 | -87.3% | 5,450 | -82.1% | 0.00% | -100.0% |
| Q1 2022 | $2,216,000 | -41.5% | 30,496 | -4.7% | 0.00% | -25.0% |
| Q4 2021 | $3,785,000 | – | 32,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |